![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TMEM209 |
Gene summary for TMEM209 |
![]() |
Gene information | Species | Human | Gene symbol | TMEM209 | Gene ID | 84928 |
Gene name | transmembrane protein 209 | |
Gene Alias | NET31 | |
Cytomap | 7q32.2 | |
Gene Type | protein-coding | GO ID | GO:0005575 | UniProtAcc | Q96SK2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
84928 | TMEM209 | P57T-E | Human | Esophagus | ESCC | 8.15e-05 | 9.95e-02 | 0.0926 |
84928 | TMEM209 | P61T-E | Human | Esophagus | ESCC | 3.98e-08 | 2.00e-01 | 0.099 |
84928 | TMEM209 | P62T-E | Human | Esophagus | ESCC | 5.02e-08 | 1.70e-01 | 0.1302 |
84928 | TMEM209 | P65T-E | Human | Esophagus | ESCC | 4.28e-08 | 1.92e-01 | 0.0978 |
84928 | TMEM209 | P74T-E | Human | Esophagus | ESCC | 7.09e-07 | 1.78e-01 | 0.1479 |
84928 | TMEM209 | P75T-E | Human | Esophagus | ESCC | 5.59e-12 | 2.70e-01 | 0.1125 |
84928 | TMEM209 | P76T-E | Human | Esophagus | ESCC | 2.78e-04 | 8.46e-02 | 0.1207 |
84928 | TMEM209 | P79T-E | Human | Esophagus | ESCC | 2.64e-21 | 4.34e-01 | 0.1154 |
84928 | TMEM209 | P80T-E | Human | Esophagus | ESCC | 1.30e-10 | 3.10e-01 | 0.155 |
84928 | TMEM209 | P83T-E | Human | Esophagus | ESCC | 1.82e-04 | 1.45e-01 | 0.1738 |
84928 | TMEM209 | P89T-E | Human | Esophagus | ESCC | 4.86e-05 | 2.86e-01 | 0.1752 |
84928 | TMEM209 | P91T-E | Human | Esophagus | ESCC | 8.74e-05 | 3.90e-01 | 0.1828 |
84928 | TMEM209 | P107T-E | Human | Esophagus | ESCC | 1.10e-10 | 2.33e-01 | 0.171 |
84928 | TMEM209 | P126T-E | Human | Esophagus | ESCC | 6.92e-05 | 2.64e-01 | 0.1125 |
84928 | TMEM209 | P127T-E | Human | Esophagus | ESCC | 1.65e-03 | 9.55e-02 | 0.0826 |
84928 | TMEM209 | P128T-E | Human | Esophagus | ESCC | 3.46e-14 | 4.10e-01 | 0.1241 |
84928 | TMEM209 | P130T-E | Human | Esophagus | ESCC | 1.01e-31 | 6.77e-01 | 0.1676 |
84928 | TMEM209 | HCC1_Meng | Human | Liver | HCC | 3.30e-67 | 1.11e-01 | 0.0246 |
84928 | TMEM209 | HCC2_Meng | Human | Liver | HCC | 4.73e-06 | 1.79e-02 | 0.0107 |
84928 | TMEM209 | HCC2 | Human | Liver | HCC | 2.30e-06 | 2.42e+00 | 0.5341 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TMEM209 | SNV | Missense_Mutation | c.736N>T | p.Leu246Phe | p.L246F | Q96SK2 | protein_coding | deleterious(0.01) | probably_damaging(0.995) | TCGA-A8-A081-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TMEM209 | SNV | Missense_Mutation | c.424N>A | p.Tyr142Asn | p.Y142N | Q96SK2 | protein_coding | deleterious(0.02) | probably_damaging(0.929) | TCGA-C8-A1HJ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
TMEM209 | SNV | Missense_Mutation | c.1030N>G | p.Asn344Asp | p.N344D | Q96SK2 | protein_coding | tolerated(0.06) | benign(0.089) | TCGA-D8-A1XQ-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TMEM209 | SNV | Missense_Mutation | novel | c.1060N>C | p.Glu354Gln | p.E354Q | Q96SK2 | protein_coding | deleterious(0) | possibly_damaging(0.86) | TCGA-XX-A89A-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TMEM209 | deletion | Frame_Shift_Del | novel | c.13delN | p.Glu5ArgfsTer15 | p.E5Rfs*15 | Q96SK2 | protein_coding | TCGA-EW-A2FV-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | docetaxel | SD | ||
TMEM209 | SNV | Missense_Mutation | novel | c.1253C>A | p.Ser418Tyr | p.S418Y | Q96SK2 | protein_coding | deleterious(0) | possibly_damaging(0.452) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
TMEM209 | SNV | Missense_Mutation | c.1289N>A | p.Arg430Lys | p.R430K | Q96SK2 | protein_coding | tolerated(1) | benign(0.003) | TCGA-EA-A3QD-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Chemotherapy | cisplatin | CR | |
TMEM209 | SNV | Missense_Mutation | c.645N>C | p.Leu215Phe | p.L215F | Q96SK2 | protein_coding | tolerated(0.16) | possibly_damaging(0.875) | TCGA-EK-A2PG-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Unknown | Unknown | SD | |
TMEM209 | SNV | Missense_Mutation | c.1105N>C | p.Glu369Gln | p.E369Q | Q96SK2 | protein_coding | deleterious(0.01) | possibly_damaging(0.721) | TCGA-VS-A8EL-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
TMEM209 | SNV | Missense_Mutation | c.574N>G | p.Leu192Val | p.L192V | Q96SK2 | protein_coding | tolerated(0.51) | benign(0) | TCGA-AA-3510-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |